Search Results
WHERE ARE THEY NOW: DR. IAN MACDONALD — CLINICAL GENETICS PIONEER AND PATIENT CHAMPION
Dr. Ian MacDonald’s illustrious career began when, as a trainee in clinical genetics he had the opportunity to work on a project funded by Fighting Blindness Canada (FBC). Choroideremia is an inherited...
READ MORELIVING LIFE TO THE FULLEST
Dagmar Jamieson has a remarkable story to tell. At age 13, she was diagnosed with a debilitating eye disease resembling macular degeneration, making it increasingly difficult to see, and the pressures of...
READ MOREACCELERATE VISION HEALTH SERIES
Over the past 50 years, Fighting Blindness Canada has played a pivotal role by investing in vision research and bringing information to Canadians. As we look toward the future of vision health...
READ MORERESEARCH NEWS
June 2025 Gene Therapy for XLRP does not meet primary endpoint in Phase 3 trial The Phase 3 LUMEOS trial studying the gene therapy botaretigene sparoparvovec (bota-vec) for X-linked retinitis pigmentosa (XLRP)...
READ MOREFROM BENCH TO BEDSIDE AND BACK AGAIN: ARVO COMES TO CANADA
The phrase “from the bench to the bedside” is often used to describe the path to new medical treatments, beginning with a discovery at the laboratory “bench” and finishing when patients can...
READ MORE“GENE THERAPY HAS ARRIVED!”
Canada’s first ocular gene therapy clinical trial was led by Dr. Ian MacDonald. The FBC was proud to be one of the funders who made this trial possible – as Dr. MacDonald...
READ MOREJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
